In one clinical trial funded by Eli Lilly, participants who took Tirzepatide 5.0 mg lost 16.1 kg of body weight, participants who took Tirzepatide 10 mg lost 22.2 kg of body weight, and participants who took Tirzepatide 15 mg lost 23.6 kg of body weight, while only 2.4 kg weight loss was observed in participants taking placebo
As insulin is cosecreted with serotonin and dopamine, these MAs also become deficient, contributing to circulatory and cardiovascular pathology which frequently accompany T2DM (Figure 2)
Food and Drug Administration to treat type 2 diabetes, weight loss and reduce the risk of cardiovascular disease.The medications are also used for weight loss, delaying gastric (stomach) emptying, decreasing hunger and reducing how much people eat
Westerink RH, Ewing AG
Typical milestones look like: Week 1: Support garments, controlled mobility, help at home recommended Week 2 3: Bruising and swelling begin to ease